The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
RNA and microRNAs in fragile X mental retardation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481 · cited 1×
“The gene responsible for fragile X syndrome, FMR1 (for fragile X mental retardation 1), is situated on the X chromosome and was cloned in 1991 (ref”
BackgroundSelf-citationFu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080 · cited 1×
“The gene responsible for fragile X syndrome, FMR1 (for fragile X mental retardation 1), is situated on the X chromosome and was cloned in 1991 (ref”
BackgroundSelf-citationRegulation of Heterochromatic Silencing and Histone H3 Lysine-9 Methylation by RNAi
Volpe, T. A., Kidner, C., Hall, I. M., Teng, G., Grewal, S. I. S., & Martienssen, R. A. (2002) · Science · doi:10.1126/science.1074973 · Cited by 2,055
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · cited 1×
“The role of FMRP in mGluR5-dependent LTD suggests new treatment approaches for fragile X syndrome, based on antagonists of mGluR5 to temper the increased translation of mGluR5-stimulated messages that occurs in the absence of FMR”
BackgroundSelf-citationInstability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome
Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M. F., & Mandel, J. L. (1991) · Science · doi:10.1126/science.252.5009.1097 · Cited by 1,499
Altered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · cited 1×
“Consistent with this idea, mGluR-LTD (but not NMDAR-LTD) is enhanced substantially in the hippocampus of Fmr1 -knockout mice, whereas LTP was unaffecte”
BackgroundSelf-citationRNAi-Mediated Targeting of Heterochromatin by the RITS Complex
Verdel, A., Jia, S., Gerber, S., Sugiyama, T., Gygi, S., Grewal, S. I. S., & Moazed, D. (2004) · Science · doi:10.1126/science.1093686 · Cited by 1,221
Brown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109
Self-citationKanai, Y., Dohmae, N., & Hirokawa, N. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.022 · Cited by 1,108
Cited by
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Regulation of mRNA Translation and Stability by microRNAs
Fabian, M. R., Sonenberg, N., & Filipowicz, W. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060308-103103 · Cited by 3,214
“One example is the fragile X mental retardation protein, FMRP, and its Drosophila ortholog, dFXR, which are RNAbinding proteins known to act as modulators of translation (71, 72).”
BackgroundDNA methylation and human disease
Robertson, K. D. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1655 · Cited by 2,864
Garzon, R., Calin, G. A., & Croce, C. M. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.59.053006.104707 · Cited by 1,770
Di Leva, G., Garofalo, M., & Croce, C. M. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104715 · Cited by 1,672
RNA-binding proteins in human genetic disease
Gebauer, F., Schwarzl, T., Valcárcel, J., & Hentze, M. W. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-00302-y · Cited by 1,176
Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function
Bassell, G. J., & Warren, S. T. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.004 · Cited by 1,051
Self-citationDiseases of Unstable Repeat Expansion: Mechanisms and Common Principles
Gatchel, J. R., & Zoghbi, H. Y. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1691 · Cited by 794
Regulation of Synaptic Structure and Function by FMRP-Associated MicroRNAs miR-125b and miR-132
Edbauer, D., Neilson, J. R., Foster, K. A., Wang, C.-F., Seeburg, D. P., Batterton, M. N., Tada, T., Dolan, B. M., Sharp, P. A., & Sheng, M. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.005 · Cited by 735
“…the RNA interference silencing complex (RISC) and with miRNAs, but FMRP itself is not essential for RNAi-mediated mRNA cleavage (Bolduc et al., 2008; Caudy et al., 2002; Cheever and Ceman, 2009; Hock et al., 2007; Ishizuka et al., 2002; Jin et al., 2004b; Okamura et al., 2004; Plante et al., 2006).”
InfluentialRNA-binding proteins in human genetic disease
Lukong, K. E., Chang, K.-W., Khandjian, E. W., & Richard, S. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.05.004 · Cited by 646
MicroRNA and cancer – A brief overview
Acunzo, M., Romano, G., Wernicke, D., & Croce, C. M. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.09.013 · Cited by 630
Intragenic tandem repeats generate functional variability
Verstrepen, K. J., Jansen, A., Lewitter, F., & Fink, G. R. (2005) · Nature Genetics · doi:10.1038/ng1618 · Cited by 616
“In humans, expansion of intragenic triplet repeats is associated with various diseases, including Huntington chorea and fragile X syndrom”
BackgroundDiverse molecular functions of Hu proteins
Hinman, M. N., & Lou, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8252-6 · Cited by 587
“Fragile X mental retardation is caused by diminished expression of the RNA-binding protein FMRP, which is involved in regulation of synaptic plasticity through binding to G quartet-containing RNA targets and affecting their transport and translation [11].”
Perkins, D. O., Jeffries, C. D., Jarskog, L. F., Thomson, J. M., Woods, K., Newman, M. A., Parker, J. S., Jin, J., & Hammond, S. M. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r27 · Cited by 574
“FMRP might regulate the translation of mRNAs through association with RISCs and miRNAs, and, in particular, might regulate translation of mRNAs locally in the dendrites [ 24- 26 ].”
BackgroundRopers, H.-H., & Hamel, B. C. J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1501 · Cited by 501
Natural selection on human microRNA binding sites inferred from SNP data
Chen, K., & Rajewsky, N. (2006) · Nature Genetics · doi:10.1038/ng1910 · Cited by 469
Practical Aspects of microRNA Target Prediction
M. Witkos, T., Koscianska, E., & J. Krzyzosiak, W. (2011) · Current Molecular Medicine · doi:10.2174/156652411794859250 · Cited by 466
microRNAs in Vertebrate Physiology and Human Disease
Chang, T.-C., & Mendell, J. T. (2007) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.8.080706.092351 · Cited by 431
MicroRNAs in Disease and Potential Therapeutic Applications
Soifer, H. S., Rossi, J. J., & Sætrom, P. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300311 · Cited by 394
Muddashetty, R. S., Nalavadi, V. C., Gross, C., Yao, X., Xing, L., Laur, O., Warren, S. T., & Bassell, G. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.006 · Cited by 364
Self-citationAnti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?
Weiler, J., Hunziker, J., & Hall, J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302654 · Cited by 371
A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability
Zalfa, F., Eleuteri, B., Dickson, K. S., Mercaldo, V., De Rubeis, S., di Penta, A., Tabolacci, E., Chiurazzi, P., Neri, G., Grant, S. G. N., et al. (2007) · Nature Neuroscience · doi:10.1038/nn1893 · Cited by 364
Zoghbi, H. Y., & Beaudet, A. L. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019497 · Cited by 362
Barbee, S. A., Estes, P. S., Cziko, A.-M., Hillebrand, J., Luedeman, R. A., Coller, J. M., Johnson, N., Howlett, I. C., Geng, C., Ueda, R., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.028 · Cited by 359
Mammalian microRNAs: a small world for fine-tuning gene expression
Sevignani, C., Calin, G. A., Siracusa, L. D., & Croce, C. M. (2006) · Mammalian Genome · doi:10.1007/s00335-005-0066-3 · Cited by 356
Dai, Y., Huang, Y.-S., Tang, M., Lv, T.-Y., Hu, C.-X., Tan, Y.-H., Xu, Z.-M., & Yin, Y.-B. (2007) · Lupus · doi:10.1177/0961203307084158 · Cited by 356
Up-Regulation of Dicer, a Component of the MicroRNA Machinery, in Prostate Adenocarcinoma
Chiosea, S., Jelezcova, E., Chandran, U., Acquafondata, M., McHale, T., Sobol, R. W., & Dhir, R. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.060480 · Cited by 347
Regulation of MicroRNA Biogenesis: A miRiad of mechanisms
Davis, B. N., & Hata, A. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-18 · Cited by 336
TDP‐43, the signature protein of FTLD‐U, is a neuronal activity‐responsive factor
Wang, I. ‐., Wu, L., Chang, H., & Shen, C. ‐. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05190.x · Cited by 335
RNA Interference: From Basic Research to Therapeutic Applications
Kurreck, J. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802092 · Cited by 335
MicroRNAs (miRNAs) in Neurodegenerative Diseases
Nelson, P. T., Wang, W., & Rajeev, B. W. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00120.x · Cited by 326
Expansion of Human-Specific GGC Repeat in Neuronal Intranuclear Inclusion Disease-Related Disorders
Tian, Y., Wang, J.-L., Huang, W., Zeng, S., Jiao, B., Liu, Z., Chen, Z., Li, Y., Wang, Y., Min, H.-X., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.05.013 · Cited by 326
Self-citationDecreased expression of the GABAA receptor in fragile X syndrome
D'Hulst, C., De Geest, N., Reeve, S. P., Van Dam, D., De Deyn, P. P., Hassan, B. A., & Kooy, R. F. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.115 · Cited by 318
“pathway or by acting as a nucleic acid chaperone (Bardoni et al., 2006; Gabus et al., 2004; Jin et al., 2004).”
BackgroundThe MicroRNA (miRNA): Overview of the RNA Genes that Modulate Gene Function
Ying, S.-Y., Chang, D. C., & Lin, S.-L. (2008) · Molecular Biotechnology · doi:10.1007/s12033-007-9013-8 · Cited by 323
Retracted: Post‐transcriptional regulation of the let‐7 microRNA during neural cell specification
Wulczyn, F. G., Smirnova, L., Rybak, A., Brandt, C., Kwidzinski, E., Ninnemann, O., Strehle, M., Seiler, A., Schumacher, S., & Nitsch, R. (2007) · The FASEB Journal · doi:10.1096/fj.06-6130com · Cited by 312
RetractedGenome-wide screen reveals APC-associated RNAs enriched in cell protrusions
Mili, S., Moissoglu, K., & Macara, I. G. (2008) · Nature · doi:10.1038/nature06888 · Cited by 298
Dysregulation and restoration of translational homeostasis in fragile X syndrome
Richter, J. D., Bassell, G. J., & Klann, E. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4001 · Cited by 275
Promoter-Bound Trinucleotide Repeat mRNA Drives Epigenetic Silencing in Fragile X Syndrome
Colak, D., Zaninovic, N., Cohen, M. S., Rosenwaks, Z., Yang, W.-Y., Gerhardt, J., Disney, M. D., & Jaffrey, S. R. (2014) · Science · doi:10.1126/science.1245831 · Cited by 294
Mehler, M. F., & Mattick, J. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00036.2006 · Cited by 293
Functional aspects of animal microRNAs
Williams, A. E. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7355-9 · Cited by 282
Nishimura, Y., Martin, C. L., Vazquez-Lopez, A., Spence, S. J., Alvarez-Retuerto, A. I., Sigman, M., Steindler, C., Pellegrini, S., Schanen, N. C., Warren, S. T., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm116 · Cited by 276
Self-citationPinheiro, I., Dejager, L., & Libert, C. (2011) · BioEssays · doi:10.1002/bies.201100047 · Cited by 273
Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients
Dai, Y., Sui, W., Lan, H., Yan, Q., Huang, H., & Huang, Y. (2009) · Rheumatology International · doi:10.1007/s00296-008-0758-6 · Cited by 265
Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila
Chang, S., Bray, S. M., Li, Z., Zarnescu, D. C., He, C., Jin, P., & Warren, S. T. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.78 · Cited by 254
Self-citationFUS pathology in basophilic inclusion body disease
Munoz, D. G., Neumann, M., Kusaka, H., Yokota, O., Ishihara, K., Terada, S., Kuroda, S., & Mackenzie, I. R. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0598-9 · Cited by 253
New modes of translational control in development, behavior, and disease.
Sonenberg, N., & Hinnebusch, A. G. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.018 · Cited by 187
RNA Protein Interaction in Neurons
Darnell, R. B. (2013) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062912-114322 · Cited by 181
ADHD symptoms in children with FXS
Sullivan, K., Hatton, D., Hammer, J., Sideris, J., Hooper, S., Ornstein, P., & Bailey, D. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31388 · Cited by 174
Abnormal Striatal GABA Transmission in the Mouse Model for the Fragile X Syndrome
Centonze, D., Rossi, S., Mercaldo, V., Napoli, I., Ciotti, M. T., De Chiara, V., Musella, A., Prosperetti, C., Calabresi, P., Bernardi, G., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.008 · Cited by 171
McKee, A. E., Minet, E., Stern, C., Riahi, S., Stiles, C. D., & Silver, P. A. (2005) · BMC Developmental Biology · doi:10.1186/1471-213x-5-14 · Cited by 166
McLennan, Y., Polussa, J., Tassone, F., & Hagerman, R. (2011) · Current Genomics · doi:10.2174/138920211795677886 · Cited by 160
Talebizadeh, Z., Butler, M. G., & Theodoro, M. F. (2008) · Autism Research · doi:10.1002/aur.33 · Cited by 157
Early developmental alterations in GABAergic protein expression in fragile X knockout mice
Adusei, D. C., Pacey, L. K. K., Chen, D., & Hampson, D. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.002 · Cited by 139
Hommelsheim, C. M., Frantzeskakis, L., Huang, M., & Ülker, B. (2014) · Scientific Reports · doi:10.1038/srep05052 · Cited by 121
Plante, I., Davidovic, L., Ouellet, D. L., Gobeil, L.-A., Tremblay, S., Khandjian, E. W., & Provost, P. (2006) · BioMed Research International · doi:10.1155/jbb/2006/64347 · Cited by 119
Yang, Y., Xu, S., Xia, L., Wang, J., Wen, S., Jin, P., & Chen, D. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000444 · Cited by 116
Self-citationTherapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back
Gross, C., Hoffmann, A., Bassell, G. J., & Berry-Kravis, E. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0355-9 · Cited by 105
Phosphorylation of FMRP inhibits association with Dicer
Cheever, A., & Ceman, S. (2009) · RNA · doi:10.1261/rna.1500809 · Cited by 81
microRNA-128a dysregulation in transgenic Huntington’s disease monkeys
Kocerha, J., Xu, Y., Prucha, M. S., Zhao, D., & Chan, A. W. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-46 · Cited by 75
Shang, Y., Wang, H., Mercaldo, V., Li, X., Chen, T., & Zhuo, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06314.x · Cited by 72
“As an RNA-binding protein, FMRP associates with large polyribosomes as part of a messenger ribonucleoprotein complex and binds to as many as 400 different brain mRNA transcripts, including its own (Jin et al. 2004).”
The targeting and functions of miRNA-383 are mediated by FMRP during spermatogenesis
Tian, H., Cao, Y.-X., Zhang, X.-S., Liao, W.-P., Yi, Y.-H., Lian, J., Liu, L., Huang, H.-L., Liu, W.-J., Yin, M.-M., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.138 · Cited by 61
“Once binding to its specific mRNA ligands, FMRP may recruit proteins of RISC along with miRNAs and promote the recognition between miRNAs and their target mRNA.(16) Until now, two miRNAs (miR-125b and miR-132)”
BackgroundDifferential translation and fragile X syndrome
Vanderklish, P. W., & Edelman, G. M. (2005) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00134.x · Cited by 59
Metadata
- Authors
- Jin, P., Alisch, R. S., & Warren, S. T.
- Venue
- Nature Cell Biology
- Published
- 2004-11
- Volume
- 6
- Issue
- 11
- Pages
- 1048-1053
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2068950572
- Cited by
- 346
- References
- 71
- FWCI
- 16.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.